NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

The journal article offered data that used "from surgery" to count from.

Dr. Bosch indicated in the ASCO presentation that if you were operated on (again, from surgery) 36 months ago and still alive, then your life expectancy is 88.2 months.

So for instance, if you were in the trial and survived for that 24 months or more, your life expectancy is about 38 months. In fact, it’s 38.6 months. If you were operated on 30 months before we did the analysis and you are alive, 67 patients at the point of analysis (MARCH 2017), your life expectancy has increased. But look, you have greater potential here. [color=red]But if you’re six months longer in that trial, suddenly your survival time, your expected survival time, the [??] term is kaplan meier-derived survival estimate, my translation is expected survival time, or survival expectancy, goes from 46.5 months to 88.2 months.[/color] I’ll give you an interpretation of that in my take home message that comes next. ~ Dr. Bosch, ASCO 2018

24 months - life expectancy is 38.6 months
30 months - life expectancy is 46.5 months
36 months - life expectancy almost doubles to 88.2 months

August 2018 would be 36 months from when the last patient was operated on.

It doesn't mean that anything will happen in August. Other than...in August, anyone in the trial still alive would have a live expectancy in KM terms of at least 88.2 months.